Atlas Trials

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Clinical trial NCT07363356 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07363356
Sponsor
Eastern Hepatobiliary Surgery Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma Resectable
Start date
2026-01-30
Primary completion
2026-10-30
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.